Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03597295
Title A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

anal canal squamous cell carcinoma

Therapies

Retifanlimab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.